The US hedge fund, run by billionaire Paul Singer, has bought a sizeable stake in GSK thanks to in part to its slumping share price in recent months, and has been grumbling about the direction ...
For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback